A citation-based method for searching scientific literature

Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig, J Salvador Saldivar, Mary Beattie, Nancy Feldman, Sharon Sand, Danielle Port, Deborah I Barragan, Esther M John, Susan L Neuhausen, Garrett P Larson. J Clin Oncol 2013
Times Cited: 101







List of co-cited articles
875 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Cynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, Luis A Herrera, Josef Herzog, Danielle Castillo, Alejandro Mohar, Clementina Castro, Lenny N Gallardo, Dolores Gallardo,[...]. Cancer 2015
55
54

Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S Ho, Charité N Ricker, Katrina J Lowstuter, Kathleen R Blazer, Gail Tomlinson,[...]. Cancer Epidemiol Biomarkers Prev 2007
75
37

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
122
28

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
223
27

High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Diana Torres, Muhammad Usman Rashid, Fabian Gil, Angela Umana, Giancarlo Ramelli, Jose Fernando Robledo, Mauricio Tawil, Lilian Torregrosa, Ignacio Briceno, Ute Hamann. Breast Cancer Res Treat 2007
67
34

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
23

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
23

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Julie Dutil, Volha A Golubeva, Alba L Pacheco-Torres, Hector J Diaz-Zabala, Jaime L Matta, Alvaro N Monteiro. Breast Cancer Res Treat 2015
47
42

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
219
19

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Magda C B Gomes, Mauricio M Costa, Radovan Borojevic, Alvaro N A Monteiro, Roberto Vieira, Sergio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang,[...]. Breast Cancer Res Treat 2007
55
32

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson, Jeffrey N Weitzel, Steven A Narod. Gynecol Oncol 2012
44
40

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
Felipe Vaca-Paniagua, Rosa María Alvarez-Gomez, Verónica Fragoso-Ontiveros, Silvia Vidal-Millan, Luis Alonso Herrera, David Cantú, Enrique Bargallo-Rocha, Alejandro Mohar, César López-Camarillo, Carlos Pérez-Plasencia. PLoS One 2012
31
54

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
C Villarreal-Garza, J N Weitzel, M Llacuachaqui, E Sifuentes, M C Magallanes-Hoyos, L Gallardo, R M Alvarez-Gómez, J Herzog, D Castillo, R Royer,[...]. Breast Cancer Res Treat 2015
43
39

Clinical significance of large rearrangements in BRCA1 and BRCA2.
Thaddeus Judkins, Eric Rosenthal, Christopher Arnell, Lynn Anne Burbidge, Wade Geary, Toby Barrus, Jeremy Schoenberger, Jeffrey Trost, Richard J Wenstrup, Benjamin B Roa. Cancer 2012
80
20

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
16

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
16

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
14

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
14

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
14

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
628
14

Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
Fernando Lara-Medina, Víctor Pérez-Sánchez, David Saavedra-Pérez, Monika Blake-Cerda, Claudia Arce, Daniel Motola-Kuba, Cynthia Villarreal-Garza, Ana Maria González-Angulo, Enrique Bargalló, Jose Luis Aguilar,[...]. Cancer 2011
128
14

BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.
Angela Rosaria Solano, Gitana Maria Aceto, Dreanina Delettieres, Serena Veschi, Maria Isabel Neuman, Eduardo Alonso, Sergio Chialina, Reinaldo Daniel Chacón, Mariani-Costantini Renato, Ernesto Jorge Podestá. Springerplus 2012
33
42

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.
J Abugattas, M Llacuachaqui, Y Sullcahuaman Allende, A Arias Velásquez, R Velarde, J Cotrina, M Garcés, M León, G Calderón, M de la Cruz,[...]. Clin Genet 2015
33
42

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Marcela Gallardo, Antonia Silva, Lorena Rubio, Carolina Alvarez, Carolina Torrealba, Mauricio Salinas, Teresa Tapia, Paola Faundez, Lorena Palma, María Eugenia Riccio,[...]. Breast Cancer Res Treat 2006
50
26

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families.
Patricio Gonzalez-Hormazabal, Sara Gutierrez-Enriquez, Daniel Gaete, Jose M Reyes, Octavio Peralta, Enrique Waugh, Fernando Gomez, Sonia Margarit, Teresa Bravo, Rafael Blanco,[...]. Breast Cancer Res Treat 2011
31
41

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
485
13

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
435
12

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
146
12

If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.
Charité Ricker, Veronica Lagos, Nancy Feldman, Susan Hiyama, Sue Fuentes, Visanth Kumar, Kelly Gonzalez, Melanie Palomares, Kathleen Blazer, Katrina Lowstuter,[...]. J Genet Couns 2006
43
27

Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Gabriela Torres-Mejía, Robert Royer, Marcia Llacuachaqui, Mohammad R Akbari, Anna R Giuliano, Louis Martínez-Matsushita, Angélica Angeles-Llerenas, Carolina Ortega-Olvera, Elad Ziv, Eduardo Lazcano-Ponce,[...]. Cancer Epidemiol Biomarkers Prev 2015
23
52

Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.
Julie Dutil, Jose L Colon-Colon, Jaime L Matta, Rebecca Sutphen, Miguel Echenique. Cancer Genet 2012
23
47

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Talia Donenberg, John Lunn, Duvaughn Curling, Theodore Turnquest, Elisa Krill-Jackson, Robert Royer, Steven A Narod, Judith Hurley. Breast Cancer Res Treat 2011
54
20

The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey.
Susan T Vadaparampil, Louise Wideroff, Nancy Breen, Edward Trapido. Cancer Epidemiol Biomarkers Prev 2006
56
19

Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
Diana Torres, Muhammad U Rashid, Antje Seidel-Renkert, Jeffrey N Weitzel, Ignacio Briceno, Ute Hamann. Breast Cancer Res Treat 2009
17
64

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.
Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Mauricio Lema, Robert Royer, Song Li, Garrett Larson, Jeffrey N Weitzel,[...]. Hered Cancer Clin Pract 2014
31
35

Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.
Michael Dean, Joseph Boland, Meredith Yeager, Kate M Im, Lisa Garland, Maria Rodriguez-Herrera, Mylen Perez, Jason Mitchell, David Roberson, Kristine Jones,[...]. Gigascience 2015
29
37

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.
Maurizia Dalla Palma, Susan M Domchek, Jill Stopfer, Julie Erlichman, Jill D Siegfried, Jessica Tigges-Cardwell, Bernard A Mason, Timothy R Rebbeck, Katherine L Nathanson. Cancer Res 2008
76
13

Clinical follow up of mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes.
Ana Laura Calderón-Garcidueñas, Pablo Ruiz-Flores, Ricardo M Cerda-Flores, Hugo A Barrera-Saldaña. Salud Publica Mex 2005
23
43

BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.
Karlena Lara, Nigmet Consigliere, Jorge Pérez, Antonietta Porco. Biol Res 2012
20
50

BRCA1 and BRCA2 mutations in a South American population.
Lilian Jara, Sandra Ampuero, Eudocia Santibáñez, Lorena Seccia, Juan Rodríguez, Mario Bustamante, Víctor Martínez, Alejandra Catenaccio, Guillermo Lay-Son, Rafael Blanco,[...]. Cancer Genet Cytogenet 2006
47
21

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, D F Easton, C Evans, J Deacon, M R Stratton. J Natl Cancer Inst 1999
630
10

Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer.
Amanda Dawn Gammon, Erin Rothwell, Rebecca Simmons, Jan T Lowery, Lori Ballinger, Deirdre A Hill, Kenneth M Boucher, Anita Yeomans Kinney. J Genet Couns 2011
32
31

BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Kristen J Vogel, Deann P Atchley, Julie Erlichman, Kristine R Broglio, Kaylene J Ready, Vicente Valero, Christopher I Amos, Gabriel N Hortobagyi, Karen H Lu, Banu Arun. J Clin Oncol 2007
47
21

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
L Delgado, G Fernández, G Grotiuz, S Cataldi, A González, N Lluveras, M Heguaburu, R Fresco, D Lens, G Sabini,[...]. Breast Cancer Res Treat 2011
17
58

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
Reshma Jagsi, Kent A Griffith, Allison W Kurian, Monica Morrow, Ann S Hamilton, John J Graff, Steven J Katz, Sarah T Hawley. J Clin Oncol 2015
59
16

Genomic Disparities in Breast Cancer Among Latinas.
Filipa Lynce, Kristi D Graves, Lina Jandorf, Charite Ricker, Eida Castro, Laura Moreno, Bianca Augusto, Laura Fejerman, Susan T Vadaparampil. Cancer Control 2016
26
38

Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
Patrícia M Machado, Rita D Brandão, Branca M Cavaco, Joana Eugénio, Sandra Bento, Mónica Nave, Paula Rodrigues, Aires Fernandes, Fátima Vaz. J Clin Oncol 2007
74
12

BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.
Pablo Ruiz-Flores, Olga M Sinilnikova, Michael Badzioch, A L Calderon-Garcidueñas, Sandrine Chopin, Odefrey Fabrice, J F González-Guerrero, Csilla Szabo, Gilbert Lenoir, David E Goldgar,[...]. Hum Mutat 2002
33
27

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
998
9

Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.
S Vidal-Millán, L Taja-Chayeb, O Gutiérrez-Hernández, M T Ramírez Ugalde, C Robles-Vidal, E Bargallo-Rocha, A Mohar-Betancourt, A Dueñas-González. Eur J Gynaecol Oncol 2009
14
64


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.